Sol-Gel Technologies (SLGL) Times Interest Earned (2017 - 2025)
Sol-Gel Technologies (SLGL) posted quarterly Times Interest Earned of -$0.06 for Q4 2025, up 52.4% year-over-year from -$0.04 in Q4 2024, and down 100.2% quarter-over-quarter from $29.79 in Q2 2025.
Sol-Gel Technologies (SLGL) Times Interest Earned (2017 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Times Interest Earned for 9 consecutive years, with -$0.06 the latest figure, recorded in Q4 2025.
- In Q4 2025, Times Interest Earned rose 52.4% year-over-year to -$0.06; the TTM figure through Mar 2026 stood at $14.29 (up 21.01% YoY), while the FY2025 annual figure was -$0.13, up 46.6% from the prior year.
- Times Interest Earned slipped to -$0.06 in Q4 2025 per SLGL's latest filing, from $29.79 in the prior quarter.
- Across five years, Times Interest Earned topped out at $34.21 in Q4 2021 and bottomed at -$0.14 in Q4 2022.
- Historically, Times Interest Earned has averaged $9.81 across 5 years, with a median of -$0.06 in 2025.
- Annual changes were most pronounced in 2022 — Times Interest Earned tumbled 100.41% — and 2025, when it surged 485.12%.
- Sol-Gel Technologies' Times Interest Earned stood at $34.21 in 2021, then plunged by 100.41% to -$0.14 in 2022, then gained by 18.71% to -$0.11 in 2023, then dropped by 8.54% to -$0.12 in 2024, then jumped by 52.4% to -$0.06 in 2025.
- Business Quant data shows SLGL's Times Interest Earned at -$0.06 in Q4 2025, $29.79 in Q2 2025, and -$0.12 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.06 |
| Jun 30, 2025 | 29.79 |
| Dec 31, 2024 | -0.12 |
| Jun 30, 2024 | 5.09 |
| Dec 31, 2023 | -0.11 |
| Dec 31, 2022 | -0.14 |
| Dec 31, 2021 | 34.21 |
| Dec 31, 2020 | -17.87 |
| Dec 31, 2019 | -146.19 |
| Jun 30, 2019 | 5.79 |
| Dec 31, 2018 | 46.31 |
| Dec 31, 2017 | 0.25 |